RadioClash is the future of enhanced electroporation therapy
A revolutionary new treatment for cancer of the liver, pancreas, and bones. Effective, more affordable, faster recovery, minimally invasive.
News and Updates
Jul 2024Biotex Partnership
RadioClash has partnered with Houston based Biotex. With over 20 years of MedTech expertise, Biotex delivers strategic guidance and a proven track record of success. From development to commercialization, [they] help turn innovative ideas into market-ready medical devices.
Sep 2024RESI Boston BioTech Week
RadioClash was the winning company in our medical device pitch cohort. We also won 3rd place in the competition overall, and were the only company developing a medical device that placed in the Top 3.
Jan 2025RESI JPM in San Francisco
A premier international medtech and biotech event. RadioClash was the winning company in our medical device pitch cohort for the Innovator's Pitch Competition.
Jan 2025HBS New Ventures Competition
Harvard Business School - Advanced to Semifinals in Atlanta, GA
Mar 2025MedTech Innovator
Advanced to West Coast RoadTour pitch cohort with a successful pitch at UCLA in early March '25.
Jun 2025MedTech Innovator
Accepted to MedTech Innovator Accelerator cohort 2025! 65 companies accepted out of 1500+.
Our Team
John Qiao, MDFounder & Chief Executive OfficerInterventional Radiology UTHealth / MD Anderson Cancer Center
Duane Bester, BS EEDirector R&D EngineeringElectrical Engineer Software & Product Developer
Damir Ljuboja, MD, MBADirector of Business DevelopmentInterventional Radiology UTHealth / MD Anderson Cancer Center
Samantha JayawickramaDirector of OperationsInformation Science & Technology Product Engineering Leader
Our Partner
Ashok Gowda, PhDBoard of DirectorsPresident BioTex, Inc. Partner, MedTex Ventures
Manish AhujaBoard of Directors ObserverCEO BioTex, Inc.
© 2025 RadioClash, Inc.